Simplex Trading’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-168
Closed -$9K 8948
2025
Q2
$9K Sell
168
-3,048
-95% -$244K ﹤0.01% 7357
2025
Q1
$348K Buy
3,216
+2,996
+1,362% +$261K ﹤0.01% 3777
2024
Q4
$10K Sell
220
-440
-67% -$26.6K ﹤0.01% 7165
2024
Q3
$64K Buy
660
+576
+686% +$74.4K ﹤0.01% 5655
2024
Q2
$13K Sell
84
-1,768
-95% -$252K ﹤0.01% 7221
2024
Q1
$282K Sell
1,852
-4,852
-72% -$807K ﹤0.01% 4475
2023
Q4
$2.1M Buy
6,704
+4,088
+156% +$1.48M ﹤0.01% 2311
2023
Q3
$1.16M Buy
2,616
+1,152
+79% +$520K ﹤0.01% 2523
2023
Q2
$634K Sell
1,464
-2,240
-60% -$1.26M ﹤0.01% 3058
2023
Q1
$2.2M Sell
3,704
-256
-6% -$143K ﹤0.01% 1864
2022
Q4
$1.6M Buy
3,960
+948
+31% +$445K ﹤0.01% 2041
2022
Q3
$1.76M Sell
3,012
-556
-16% -$333K ﹤0.01% 2070
2022
Q2
$1.95M Buy
3,568
+3,300
+1,231% +$1.67M ﹤0.01% 1897
2022
Q1
$169K Buy
268
+236
+738% +$122K ﹤0.01% 5388
2021
Q4
$21K Buy
+32
New +$19.5K ﹤0.01% 8291

Other funds holding AGL

Simplex Trading's AGL Position: Q1 2026 in Review

Simplex Trading reduced its Agilon Health (AGL) stake by 6.6% in Q1 2026, selling an estimated $4.87K and leaving 4,245 shares worth $33.6K. The position accounts for ﹤0.01% of the portfolio, ranked #6275.

Simplex Trading first reported a position in AGL in Q2 2021 and has held it in 15 quarters since. The position peaked at $1.35M in Q3 2023. 97 funds tracked by Wall St. Rank hold AGL as of Q1 2026.

  • Simplex Trading held 4,245 shares of Agilon Health worth $33.6K as of Q1 2026.
  • Simplex Trading sold 301 Agilon Health shares in Q1 2026, an estimated $4.87K.
  • Agilon Health made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #6275 holding.
  • Simplex Trading first reported a position in Agilon Health in Q2 2021 and has held it in 15 quarters since.
  • Simplex Trading's Agilon Health position peaked at $1.35M in Q3 2023.
  • 97 funds tracked by Wall St. Rank held Agilon Health as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.